Multiple-azole-resistant Aspergillus fumigatus osteomyelitis in a patient with chronic granulomatous disease successfully treated with long-term oral posaconazole and surgery

References

• Winkelstein JA, Marino MC, Johnston RB Jr, et al. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore) 2000; 79: 155–169
   PubMed Web of Science ®Google Scholar
• Van den Berg JM, Van Koppen E, Åhlin A, , et al. Chronic granulomatous disease (CGD): A European database. In: 13th International Congress of Immunology. Rio de Janeiro, Brazil; 2007 [abstract MS-17.2].
   Google Scholar
• Gallin JI, Alling DW, Malech HL, et al. Itraconazole to prevent fungal infections in chronic granulomatous disease. N Engl J Med 2003; 348: 2416–2422
   PubMed Web of Science ®Google Scholar
• Raad II, Graybill JR, Bustamante AB, et al. Safety of long-term oral posaconazole use in the treatment of refractory invasive fungal infections. Clin Infect Dis 2006; 42: 1726–1734
   PubMed Web of Science ®Google Scholar
• Segal BH, Barnhart LA, Anderson VL, et al. Posaconazole as salvage therapy in patients with chronic granulomatous disease and invasive filamentous fungal infection. Clin Infect Dis 2005; 40: 1684–1688
   PubMed Web of Science ®Google Scholar
• Leusen JH, de Boer M, Bolscher BG, et al. A point mutation in gp91-phox of cytochrome b558 of the human NADPH oxidase leading to defective translocation of the cytosolic proteins p47-phox and p67-phox. J Clin Invest 1994; 93: 2120–2126
   PubMed Web of Science ®Google Scholar
• National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved standard M38-A. National Committee for Clinical Laboratory Standards, Wayne, PA, 2002
   Google Scholar
• Mellado E, Garcia-Effron G, Alcázar-Fuoli L, et al. A new Aspergillus fumigatus resistance mechanism conferring in vitro crossresistance to azole antifungals involves a combination of cyp51A alterations. Antimicrob Agents Chemother 2007; 51: 1897–1904
   PubMed Web of Science ®Google Scholar
• Samson RA, Hong SB, Peterson SW, Frisvad JC, Varga J. Polyphasic taxonomy of Aspergillus section Fumigati and its teleomorph, Neosartorya. Stud Mycol 2007; 59: 147–203
   PubMed Web of Science ®Google Scholar
• Dotis J, Roilides E. Osteomyelitis due to Aspergillus spp. in patients with chronic granulomatous disease: comparison of Aspergillus nidulans and Aspergillus fumigatus. Int J Infect Dis 2004; 8: 103–110
   PubMed Web of Science ®Google Scholar
• Mouas H, Lutsar I, Dupont B, et al. and the Voriconazole/Bone Invasive Aspergillosis Study Group. Voriconazole for invasive bone aspergillosis: a worldwide experience of 20 cases. Clin Infect Dis 2005; 40: 1141–1147
   PubMed Web of Science ®Google Scholar
• Lodge BA, Ashley ED, Steele MP, Perfect JR. Aspergillus fumigatus empyema, arthritis, and calcaneal osteomyelitis in a lung transplant patient successfully treated with posaconazole. J Clin Microbiol 2004; 42: 1376–1378
   PubMed Web of Science ®Google Scholar
• Mosquera J, Denning DW. Azole cross-resistance in Aspergillus fumigatus. Antimicrob Agents Chemother 2002; 46: 556–557
   PubMed Web of Science ®Google Scholar
• Krishna G, Sansone-Parsons A, Martinho M, Kantesaria B, Pedicone L. Posaconazole plasma concentrations in juvenile patients with invasive fungal infection. Antimicrob Agents Chemother 2007; 51: 812–818
   PubMed Web of Science ®Google Scholar
• Verweij PE, Van der Lee HAL, Kuijpers J, , et al. Epidemiology of multiple-triazole-resistant Aspergillus fumigatus. In: 47th Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago, IL: American Society for Microbiology, 2007 [abstract M-2018].
   Google Scholar
• Verweij PE, Mellado E, Melchers WJ. Multiple-triazole-resistant aspergillosis. N Engl J Med 2007; 356: 1481–1483
   PubMed Web of Science ®Google Scholar
• Mellado E, Alcazar-Fuoli L, Pajkrt D, , et al. Alterations of the cyp51A gene promoter contribute to Aspergillus fumigatus multiple triazole resistance. In: 47th Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago, IL: American Society for Microbiology, 2007 [abstract M-521].
   Google Scholar